Live GMAT classes with Target Test Prep start Nov 21 and Nov 22. First class free.

See classes
Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

Newsweek Readers’ Choice Awards 2026 winner: Target Test Prep, #1 Test Prep

Target Test Prep was voted #1 Best Test Prep in the 2026 Newsweek Readers’ Choice™ Awards.

★★★★★5.0563 reviews
GMATLiveTeachStarts Nov 22
Josh Braslow, Target Test Prep GMAT expert
LIVE ONLINE CLASSES

Get Ready for GMAT Test Day Faster with Live Online Classes

with Josh Braslow, 20+ years in test prep

Nov 22 · Josh Braslow
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes + 6 months of TTP OnDemand
  • Attend the first class for free
  • Every class is recorded, so you never fall behind
View classes & enroll
Limited seats availableTarget Test Prep
EALiveTeachOnDemandStart anytime
EXECUTIVE ASSESSMENT

Target Test Prep EA OnDemand

Self-paced EA prep. Study on your schedule.

EXECUTIVE ASSESSMENT

with

165+ EA score guarantee
$05-day trial no automatic billing
Schedule
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll Start free 5-day trial
Limited cohort · enrollment openTrial includes full course accessTarget Test Prep
GMATOnDemandStart anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Influenza Vaccines

Expert replies
by ranjeet75 » Sat May 14, 2011 10:17 pm
Until now, only injectable vaccines against influenza have been available. Parents are reluctant
to subject children to the pain of injections, but adults, who are at risk of serious complications
from influenza, are commonly vaccinated. A new influenza vaccine, administered painlessly in a nasal spray, is effective for children. However, since children seldom develop serious complications from influenza, no significant public health benefit would result from widespread vaccination of children using the nasal spray.

Which of the following is an assumption on which the argument depends?

A. Any person who has received the injectable vaccine can safely receive the nasal-spray vaccine
as well.
B. The new vaccine uses the same mechanism to ward off influenza as jnjectable vaccines do.
C. The injectable vaccine is affordable for all adults.
D. Adults do not contract influenza primarily from children who have influenza.
E. The nasal spray vaccine is not effective when administered to adults.

OA is [spoiler]D[/spoiler]

IMO [spoiler]E[/spoiler]

My reasoning is if children is not benefitted by the vaccine because influenza is rare in them and adults can take it effectively in any way (injection or oral) then the vaccine is not useful only if it is not effective to adults. Please guide where I am wrong
Join the discussion
Source: — Critical Reasoning |

by HSPA » Sat May 14, 2011 10:24 pm
E is out because

We are talking about benifit from vaccination childern using nasal spray.

Other way:
Now let us negate E,
Nasal spray is effective for adults

Hope ths helps

Does this statement weaken the above conclusion. No...
First take: 640 (50M, 27V) - RC needs 300% improvement
Second take: coming soon..
Regards,
HSPA.
Join the discussion